AU7468596A - Process for the preparation of a growth hormone secretagogue - Google Patents

Process for the preparation of a growth hormone secretagogue

Info

Publication number
AU7468596A
AU7468596A AU74685/96A AU7468596A AU7468596A AU 7468596 A AU7468596 A AU 7468596A AU 74685/96 A AU74685/96 A AU 74685/96A AU 7468596 A AU7468596 A AU 7468596A AU 7468596 A AU7468596 A AU 7468596A
Authority
AU
Australia
Prior art keywords
compound
formula
acid
amino
protecting group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU74685/96A
Other languages
English (en)
Inventor
Peter G. Houghton
Ioannis Houpis
Joseph E Lynch
Audrey Molina
Ralph P. Volante
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9602949.1A external-priority patent/GB9602949D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU7468596A publication Critical patent/AU7468596A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU74685/96A 1995-10-27 1996-10-23 Process for the preparation of a growth hormone secretagogue Abandoned AU7468596A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US005898 1987-01-21
US589895P 1995-10-27 1995-10-27
GB9602949 1996-02-13
GBGB9602949.1A GB9602949D0 (en) 1996-02-13 1996-02-13 Process for the preparation of a growth hormone secretagogue
PCT/US1996/016954 WO1997015573A1 (en) 1995-10-27 1996-10-23 Process for the preparation of a growth hormone secretagogue

Publications (1)

Publication Number Publication Date
AU7468596A true AU7468596A (en) 1997-05-15

Family

ID=26308687

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74685/96A Abandoned AU7468596A (en) 1995-10-27 1996-10-23 Process for the preparation of a growth hormone secretagogue

Country Status (14)

Country Link
EP (1) EP0863900A1 (hu)
JP (1) JPH11513984A (hu)
KR (1) KR19990067097A (hu)
AR (1) AR004124A1 (hu)
AU (1) AU7468596A (hu)
BR (1) BR9610887A (hu)
CA (1) CA2235511A1 (hu)
CZ (1) CZ128298A3 (hu)
HR (1) HRP960494A2 (hu)
HU (1) HUP9902095A3 (hu)
PL (1) PL326428A1 (hu)
SK (1) SK51198A3 (hu)
WO (1) WO1997015573A1 (hu)
YU (1) YU56596A (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601724D0 (en) * 1996-01-29 1996-03-27 Merck Sharp & Dohme Therapeutic agents
WO1998018815A1 (en) * 1996-10-25 1998-05-07 Merck & Co., Inc. Convergent process for the preparation of a growth hormone secretagogue
US6329342B1 (en) 1997-08-19 2001-12-11 Eli Lilly And Company Treatment of congestive heart failure with growth hormone secretagogues
US6639076B1 (en) 1998-08-18 2003-10-28 Eli Lilly And Company Growth hormone secretagogues
US6828331B1 (en) 1999-02-19 2004-12-07 Eli Lilly And Company Growth hormone secretagogues
ES2333097T3 (es) 2000-05-31 2010-02-17 Raqualia Pharma Inc Uso de secretagogos de la hormona de crecimiento para estimular la motilidad gastrointestinal.
US7125840B2 (en) 2001-10-09 2006-10-24 Eli Lilly And Company Substituted dipeptides as growth hormone secretagogues
WO2003087069A2 (en) 2002-04-09 2003-10-23 Eli Lilly And Company Dipeptidic growth hormone secretagogues
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
KR20090107088A (ko) 2007-02-09 2009-10-12 트랜자임 파르마 인크 거대고리 그렐린 수용체 조절제 및 이의 사용 방법
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
WO2017075535A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL176993B1 (pl) * 1992-12-11 1999-08-31 Merck & Co Inc Nowe związki spiropiperydynowe oraz sposób ich wytwarzania

Also Published As

Publication number Publication date
SK51198A3 (en) 1998-11-04
KR19990067097A (ko) 1999-08-16
CA2235511A1 (en) 1997-05-01
AR004124A1 (es) 1998-09-30
YU56596A (sh) 1999-09-27
EP0863900A1 (en) 1998-09-16
MX9803316A (es) 1998-09-30
JPH11513984A (ja) 1999-11-30
BR9610887A (pt) 1999-07-13
CZ128298A3 (cs) 1998-07-15
HUP9902095A3 (en) 2001-05-28
HRP960494A2 (en) 1998-04-30
PL326428A1 (en) 1998-09-14
WO1997015573A1 (en) 1997-05-01
HUP9902095A2 (hu) 1999-10-28

Similar Documents

Publication Publication Date Title
US5723616A (en) Process for the preparation of a growth hormone secretagogue
US5767124A (en) Polymorphic forms of a growth hormone secretagogue
SK75995A3 (en) Spiropiperidine derivatives, method of their production and pharmaceutical agent containing them
US5804578A (en) Piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
AU7468596A (en) Process for the preparation of a growth hormone secretagogue
US6235876B1 (en) Liquid phase process for the preparation of GNRH peptides
WO1994015956A1 (en) Endothelin converting enzyme inhibitors
US5965565A (en) Piperidines promote release of growth hormone
US5880125A (en) 4-spiroindoline piperidines promote release of growth hormone
CN106188231A (zh) 帕西瑞肽五肽中间体的合成与应用
WO1998018815A1 (en) Convergent process for the preparation of a growth hormone secretagogue
US6046333A (en) Convergent process for the preparation of a growth hormone secretagogue
WO1998025897A1 (en) Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
EP0823904A1 (en) Process for the preparation of spiroindolines
US6028196A (en) Process for the preparation of a growth hormone secretagogue
US4691008A (en) Process for the low-racemization preparation of peptide intermediates of the synthesis of gonadorelin and gonadorelin analogs, and new intermediates for this process
JPS60231697A (ja) ペプチド
EP1200432A1 (en) Amido spiropiperidines promote the release of growth hormone
WO1993006127A1 (en) Novel amino acid prodrug renin inhibitors
MXPA98003316A (en) Procedure for preparing a secretagogo de hormona de crecimie
AU707946B2 (en) Polymorphic forms of a growth hormone secretagogue
CA1131217A (en) Psycho-pharmacological peptides
JP2000501083A (ja) 改善された作用効果を有する新規lh―rh―拮抗剤
EP0393786B1 (en) New retro-inverse, one- or more bond bearing analogues of thymopentin, a method for synthesizing the same and their employment for the preparation of pharmaceutical
JP2002517514A (ja) 成長ホルモン放出特性を有する化合物を調製するための方法